Andrew D. Schiermeier
Overview
Andrew D. Schiermeier received an average of $2M in total compensation, including $424K in salary, at Intellia Therapeutics between 2018 and 2019.
Source: SEC filings on April 24, 2020 and April 16, 2019.
Related executives
We found eight more executives who work or worked at Intellia Therapeutics.
James Basta
Intellia Therapeutics
General Counsel
John Leonard
Intellia Therapeutics
Chief Executive Officer
Laura Sepp-Lorenzino
Intellia Therapeutics
Chief Scientific Officer
David Lebwohl
Intellia Therapeutics
Chief Medical Officer
Glenn Goddard
Intellia Therapeutics
Chief Financial Officer
José Rivera
Intellia Therapeutics
General Counsel
Graeme Bell
Intellia Therapeutics
Chief Financial Officer
Nessan Bermingham
Intellia Therapeutics